• NextCure Form 3 disclosed ADAR1 Capital Management as a 10% owner, reporting indirect beneficial ownership of 375,658 common shares.
• Filing event date listed as July 27, 2026; report signed July 29, 2026.
• Daniel Schneeberger also reported as a 10% owner in the same filing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000011), on July 29, 2026, and is solely responsible for the information contained therein.